A PHASE I/IB SINGLE ARM STUDY OF TWO FRACTION SBRT WITH DOMINANT LESION SIB FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Prostate Cancer
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male
  • Other Inclusion Criteria:
    To participate in the study the following conditions must be met:
    1. 1) Prostate cancer that hasn't spread outside of the prostate gland
    2. 2) A sample of tissue was taken from the prostate gland and examined under a microscope, confirming that the person has prostate cancer of the adenocarcinoma type
    3. 3) A stage of prostate cancer that has been classified by the National Comprehensive Cancer Network (NCCN) as having a low to moderate risk of growing and spreading quickly

You may not be eligible for this study if the following are true:

  • You will not be able to participate in the study if:
    1. 1) You have have a stage of cancer that has a higher chance of growing and spreading quickly
    2. 2) Cancer cells have been found in the lymph nodes located in the pelvic area, which is the lower part of the abdomen
    3. 3) During a clinical exam or imaging test, there are signs that the prostate cancer has grown beyond the capsule (outer covering) of the prostate gland or has spread to the seminal vesicles, which are small glands located near the prostate



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.